Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:QDEL - US2197981051 - Common Stock

33.52 USD
+0.16 (+0.48%)
Last: 1/13/2026, 2:17:10 PM
Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 185 industry peers in the Health Care Equipment & Supplies industry. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative. QDEL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
Each year in the past 5 years QDEL had a positive operating cash flow.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

QDEL's Return On Assets of -20.78% is in line compared to the rest of the industry. QDEL outperforms 52.97% of its industry peers.
With a Return On Equity value of -57.90%, QDEL perfoms like the industry average, outperforming 47.57% of the companies in the same industry.
QDEL's Return On Invested Capital of 1.74% is fine compared to the rest of the industry. QDEL outperforms 67.57% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.84%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

QDEL has a Operating Margin of 3.98%. This is in the better half of the industry: QDEL outperforms 68.11% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
QDEL has a Gross Margin (47.15%) which is in line with its industry peers.
QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
QDEL has more shares outstanding than it did 5 years ago.
QDEL has a worse debt/assets ratio than last year.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

QDEL has an Altman-Z score of 0.83. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
QDEL has a Altman-Z score of 0.83. This is comparable to the rest of the industry: QDEL outperforms 48.11% of its industry peers.
A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
With a Debt to Equity ratio value of 1.23, QDEL is not doing good in the industry: 77.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.17
WACC10.12%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
QDEL has a Current ratio of 1.78. This is in the lower half of the industry: QDEL underperforms 67.03% of its industry peers.
A Quick Ratio of 0.98 indicates that QDEL may have some problems paying its short term obligations.
The Quick ratio of QDEL (0.98) is worse than 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The earnings per share for QDEL have decreased by -4.18% in the last year.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -3.67% in the last year.
The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%

3.2 Future

The Earnings Per Share is expected to grow by 21.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 1.98% on average per year.
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.27%
Revenue Next 5Y1.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.64, QDEL is valued correctly.
Based on the Price/Earnings ratio, QDEL is valued cheaper than 89.73% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.25, QDEL is valued a bit cheaper.
QDEL is valuated correctly with a Price/Forward Earnings ratio of 12.97.
QDEL's Price/Forward Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 92.97% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. QDEL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.64
Fwd PE 12.97
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

93.51% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.83
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 21.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y18.22%
EPS Next 3Y21.95%

0

5. Dividend

5.1 Amount

QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

QUIDELORTHO CORP

NASDAQ:QDEL (1/13/2026, 2:17:10 PM)

33.52

+0.16 (+0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners123.47%
Inst Owner Change-0.06%
Ins Owners0.61%
Ins Owner Change0.71%
Market Cap2.28B
Revenue(TTM)2.71B
Net Income(TTM)-1.18B
Analysts74.29
Price Target37.59 (12.14%)
Short Float %16.97%
Short Ratio8.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)0%
PT rev (3m)-10.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.76%
EPS NY rev (1m)-2.07%
EPS NY rev (3m)-11.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.31%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 14.64
Fwd PE 12.97
P/S 0.84
P/FCF N/A
P/OCF 61.05
P/B 1.12
P/tB N/A
EV/EBITDA 8.83
EPS(TTM)2.29
EY6.83%
EPS(NY)2.59
Fwd EY7.71%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY1.64%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.99
PEG (5Y)N/A
Graham Number39.3
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.83
F-Score5
WACC10.12%
ROIC/WACC0.17
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.27%
Revenue Next 5Y1.98%
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year938.62%
EBIT Next 3Y132.95%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 5 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 14.64 and the Price/Book (PB) ratio is 1.12.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 14.78% in the next year.